TABLE-Phoenixbio - 6-MTH group results

About this update from Phoenixbio Co., Ltd.

Nov 14 (Reuters)- Phoenixbio Co., Ltd. CONSOLIDATED FINANCIAL HIGHLIGHTS (in billions of yen unless specified) 6 months ended 6 months ended Year to Sep 30, 2025 Sep 30, 2024 Mar 31, 2026 LATEST YEAR-AGO LATEST RESULTS RESULTS FORECAST Sales 756 mln 788 mln 1.64 (-4.0 pct) (-10.6 pct) (+6.4 pct) Operating 5 mln loss 98 mln 109 mln Recurring 16 mln loss 123 mln 116 mln Net 12 mln loss 124 mln 110 mln EPS 3.03 yen loss 30.89 yen 27.13 yen Ann Div NIL NIL -Q2 div NIL NIL -Q4 div NIL NIL NOTE - Phoenixbio Co., Ltd.. To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=6190.T

View stock analysis, news, and events for Phoenixbio Co., Ltd.